Preferences for dialysis withdrawal and engagement in advance care planning within a diverse sample of dialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 237-242

  Tamura, Manjula Kurella ^a,b   Goldstein, Mary K ^a,b   Pérez Stable, Eliseo J ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advance care planning; Dialysis withdrawal; Elderly; Race; Treatment preferences

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; ASIAN; COMORBIDITY; CONTROLLED STUDY; DOCUMENTATION; EDUCATIONAL STATUS; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GROUPS BY AGE; HEALTH CARE PLANNING; HEALTH STATUS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISPANIC; HUMAN; KIDNEY FAILURE; LIVING WILL; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; TREATMENT WITHDRAWAL;

ADVANCE CARE PLANNING; ADVANCE DIRECTIVES; AFRICAN AMERICANS; AGE FACTORS; AGED; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HISPANIC AMERICANS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT PREFERENCE; RENAL DIALYSIS; RESUSCITATION ORDERS; WITHHOLDING TREATMENT;

EID: 72949123923     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp430     Document Type: Article

References (58)

1. Kurella M, Kimmel PL, Young BS et al. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 2005; 16: 774-781
2. Port FK, Wolfe RA, Hawthorne VM et al. Discontinuation of dialysis therapy as a cause of death. Am J Nephrol 1989; 9: 145-149
3. Galla JH. The Renal Physicians Association and the American Society of Nephrology. Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. J Am Soc Nephrol 2000; 11: 1340-1342
4. Cohen LM, Germain MJ, Poppel DM. Practical considerations in dialysis withdrawal: 'to have that option is a blessing'. JAMA 2003; 289: 2113-2119
5. Holley JL, Nespor S, Rault R. The effects of providing chronic hemodialysis patients written material on advance directives. Am J Kidney Dis 1993; 22: 413-418
6. Holley JL, Stackiewicz L, Dacko C et al. Factors influencing dialysis patients' completion of advance directives. Am J Kidney Dis 1997; 30: 356-360
7. Sehgal AR, Weisheit C, Miura Y et al. Advance directives and withdrawal of dialysis in the United States, Germany, and Japan. JAMA 1996; 276: 1652-1656
8. Pruchno RA, Lemay EP, Jr, Feild L et al. Predictors of patient treatment preferences and spouse substituted judgments: the case of dialysis continuation. Med Decis Making 2006; 26: 112-121
9. Sudore RL, Schickedanz AD, Landefeld CS et al. Engagement in multiple steps of the advance care planning process: a descriptive study of diverse older adults. J Am Geriatr Soc 2008; 56: 1006-1013
10. Johnson KS, Kuchibhatla M, Tulsky JA. What explains racial differences in the use of advance directives and attitudes toward hospice care? J Am Geriatr Soc 2008; 56: 1953-1958
11. Davison SN, Torgunrud C. The creation of an advance care planning process for patients with ESRD. Am J Kidney Dis 2007; 49: 27-36
12. Singer PA, Martin DK, Lavery JV et al. Reconceptualizing advance care planning from the patient's perspective. Arch Intern Med 1998; 158: 879-884
13. Wenger NS, Kanouse DE, Collins RL et al. End-of-life discussions and preferences among persons with HIV. JAMA 2001; 285: 2880-2887
14. Singer PA, Thiel EC, Naylor CD et al. Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives. J Am Soc Nephrol 1995; 6: 1410-1417
15. Kimmel PL, Peterson RA, Weihs KL et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998; 54: 245-254
16. Burke WJ, RoccaforteWH, Wengel SP. The shortform ofthe Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4: 173-178
17. Kimmel PL, Emont SL, Newmann JM et al. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis 2003; 42: 713-721
18. Beddhu S, Bruns FJ, Saul M et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000; 108: 609-613
19. Miura Y, Asai A, Nagata S et al. Dialysis patients' preferences regarding cardiopulmonary resuscitation and withdrawal of dialysis in Japan. Am J Kidney Dis 2001; 37: 1216-1222
20. Tsevat J, Cook EF, Green ML et al. Health values of the seriously ill. SUPPORT investigators. Ann Intern Med 1995; 122: 514-520
21. Hamel MB, Teno JM, Goldman L et al. SUPPORT Investigators. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. Study to understand prognoses and preferences for outcomes and risks oftreatment.Ann Intern Med 1999; 130: 116-125
22. Clarke DE, Goldstein MK, Raffin TA. Ethical dilemmas in the critically ill elderly. Clin Geriatr Med 1994; 10: 91-101
23. Mebane EW, Oman RF, Kroonen LT et al. The influence of physician race, age, and gender on physician attitudes toward advance care directives and preferences for end-of-life decision-making. J Am Geriatr Soc 1999; 47: 579-591
24. Kwak J, Haley WE. Current research findings on end-of-life decision making among racially or ethnically diverse groups. Gerontologist 2005; 45: 634-641
25. Welch LC, Teno JM, Mor V. End-of-life care in black and white: race matters for medical care of dying patients and their families. J Am Geriatr Soc 2005; 53: 1145-1153
26. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ 2006; 333: 886
27. Wright AA, Zhang B, Ray A et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673
28. Zhang B, Wright AA, Huskamp HA et al. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 2009; 169: 480-488
29. Fried TR, Bradley EH, Towle VR et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002; 346: 1061-1066
30. Moser B, Roth G, Brunner M et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 2003; 308: 581-585
31. Joon J, Gollapudi S, Pahl M et al. Näive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 2006; 70: 371-376
32. Sarantopoulos S, Stevenson KE, Kim HT et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 2007; 13: 6107-6114
33. Mackay F, Schneider P, Rennert R et al. BAFF and April: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264 (Pubitemid 37174532)
34. Mayne C, Amanna I, Nashold F et al. Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur J Immunol 2008; 38: 587-598
35. Raskova J, Ghobrial I, Czerwinski DK et al. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987; 147: 89-93
36. Balin SJ, Platt JL, Cascalho M. Noncognate function of B cells in transplantation. Transplantation 2009; 22: 593-598
37. Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997; 18: 343-350
38. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of Toll-Like receptor 1-10 mRNA in cellular subsetsof human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynu-cleotides J Immunol 2002; 168: 4531-4537
39. Bernasconi NL, Onai N,Lanzavecchia A.Arole for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101: 4500-5450
40. Johnson S, Shah N, Panoskaltsis-Mortari A et al. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J Immunol 2005; 175: 7325-7331
41. Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol 2006; 18: 20-30
42. Sims G, Ettinger R, Shirota Y et al. Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390-4398
43. Wardemann H,YurasovS,Schaefer Aet al. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-1377
44. Waldschmidt T, Noelle R. Long live the mature B cell, a BAFFling mystery resolved. Science 2001; 293: 2012-2013
45. Kalled L. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006; 18: 290-296
46. Woodland R, Schmidt M, Thompson C. BLyS and B cell homeostasis. Semin Immunol 2006; 18: 318-326
47. Kipps T. The CD5 B cell. Adv Immunol 1989; 47: 117-185
48. Herzenberg L, Haughton G, Rajewsky K. CD5 B cells in development and disease. Ann NY Acad Sci 1992; 651: 591-601
49. Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001; 13: 195-201
50. Uckun F. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908-1923
51. Gray D. Immunological memory: a function of antigen persistence. Trends Microbiol 1993; 1: 39-41 (Pubitemid 223005871)
52. Bouts A, Davin J, Krediet R et al. Children with chronic renal failure have reduced numbers of memory B cells. Clin Exp Immunol 2004; 137: 589-594
53. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996; 16: 183-191
54. Raska K Jr, Raskova J, Shea SM et al. T cell subsets and cellular immunity in end-stage renal disease. Am J Med 1983; 75: 734-740
55. Degiannis D, Mowat AM, Galloway E et al. In-vitro analysis of B lymphocyte function in uraemia. Clin Exp Immunol 1987; 70: 463-470
56. Fernández-Fresnedo G, Ramos MA, González-Pardo MC et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 2000; 15: 502-510
57. Hoy WE, Cestero RV, Freeman RB. Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis. Nephron 1978; 20: 182-188
58. Deenitchina SS, Ando T, Okuda S et al. Cellular immunity in hemodialysis patients: a quatitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995; 15: 57-65